Keep an eye out for what is happening in the world of spinal muscular atrophy (SMA) events. All over the world events take place discussing the latest advances in SMA and SMA care, which could prove to be useful in your practice.
Share page
DISCOVER BIOGEN’S COMMITMENT IN CONTINUOUS RESEARCH IN THE FIELD OF SMA AT ONE OF THE UPCOMING CONGRESSES.
We at Biogen are delighted to take the opportunity of key congresses to share important advances in the field of SMA, because through ongoing research, Biogen is dedicated to supporting the lives of those with SMA and their families.
The ICNMD International Congress on Neuromuscular Diseases is organized on behalf of the Neuromuscular Disorders Applied Research Group of the World Federation of Neurology.
The aim of the ICNMD Congresses is to offer attendees an updated view on neuromuscular disorders and that networking opportunities increase their international experience and collaborations. The scientific and program committee are invited from all continents around the world to enable this wide spectrum.
In 2021, the 7th Congress of the European Academy of Neurology will go virtual. This annual congress attracts more than 6,000 delegates each year to share research results and exchange current best practices.
The mission of the European Academy of Neurology is to promote neurological excellence in Europe and across the world, leading to better patient care and outcomes.
The executive board of the World Muscle Society has announced that the congress in 2021 will go virtual. This is done to facilitate planning for the meeting, so that WMS members, sponsors, and participants can attend.
The World Muscle Society aims at providing a multidisciplinary scientific forum to advance and disseminate knowledge in neuromuscular field for the benefit of patients and at encouraging the development of programs for professionals working in the neuromuscular field.
At Biogen, we are committed to supporting those with spinal muscular atrophy and their care teams. Our hope for Together in SMA is that by providing educational materials and resources, we can help you tackle the challenges your SMA patients face.
Together in SMA was created in support of that unity, and with the goal of becoming a valued tool for members of the team. Here you’ll find clinical information and care strategies that some people use to help manage the disease.
Biogen is building on our legacy of rare disease research and development to explore potential treatment options. And even then, we’ll still be together in SMA.
